Immunogenicity of CD63 in a patient with melanoma.

Melanoma Res

Oncology and Immunology Unit, David Maddison Clinical Sciences Building, Newcastle, NSW, Australia.

Published: August 1997

CD63 is a member of the tetraspan family of molecules that is expressed in melanoma and which appears to be involved in regulation of motility and adhesion of melanoma cells. In the present study we have screened a cDNA library from a melanoma cell with antisera from a patient with melanoma and have shown that one of the antigens identified was CD63. The clone isolated contained a mutation in the transmembrane region, but this did not appear to be involved in immunogenicity of the molecule. Antisera from the patient showed weak reactivity with CD63 from melanoma and recombinant CD63 in Western blots. The latter studies showed marked variation in the fractions of CD63 identified with monoclonal antibodies to CD63 consistent with variable glycosylation of CD63. We suggest that glycosylation may account for its recognition by the human immune system. Further studies are required to assess the role of CD63 as an immunogen in melanoma.

Download full-text PDF

Source

Publication Analysis

Top Keywords

patient melanoma
8
cd63
8
antisera patient
8
melanoma
7
immunogenicity cd63
4
cd63 patient
4
melanoma cd63
4
cd63 member
4
member tetraspan
4
tetraspan family
4

Similar Publications

Purpose: Precision medicine plays an important role in the treatment of patients with advanced melanoma. Despite its high incidence in White patients, advanced melanoma is rare in Asian countries, hampering prospective clinical trials targeting the Asian population. This retrospective study aimed to elucidate the real-world molecular diagnoses and outcomes of Japanese patients with melanoma using comprehensive genome profiling (CGP).

View Article and Find Full Text PDF

Introduction: Basal cell carcinoma (BCC) is the most common type of skin malignancy, accounting for approximately 80% of all non-melanoma skin cancers (NMSCs). Ultraviolet (UV) exposure is a significant risk factor for BCC development, which typically occurs in sun-exposed areas. BCC arising in non-sun-exposed regions, such as the nipple-areola complex (NAC), is exceedingly rare, with fewer than 100 cases reported globally.

View Article and Find Full Text PDF

Melanoma is a highly aggressive malignancy originating from melanocytes, characterized by its potential to arise in various anatomic locations, both common and rare. The incidence of melanoma has been steadily increasing globally, with variations in clinical presentation, tumor behavior, and prognosis depending on the anatomical site involved. Understanding the diverse pathological spectrum of melanoma is critical for optimizing diagnostic and therapeutic strategies.

View Article and Find Full Text PDF

Anti-melanoma differentiation-associated protein 5 (anti-MDA5) clinically linked amyopathic dermatomyositis (CADM) is a rare autoimmune condition strongly linked to rapidly progressive interstitial lung disease (RP-ILD), a life-threatening complication. We present a 63-year-old female patient with anti-MDA5-positive CADM, who developed RP-ILD with an imaging pattern consistent with organizing pneumonia. She presented with Gottron's papules, periungual erythema, progressive dyspnea, and anorexia.

View Article and Find Full Text PDF

Background: The relationship between particulate matter (PM) exposure and melanoma risk remains largely unexplored. This study aims to investigate the association between PM10 and PM2.5 long-term exposure and melanoma risk.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!